At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Oral Nicotine +2 moredrug
Likely dose
Nicotine Lozenge 4 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product. A Study in Healthy Smokers.
In Brief
A clinical study evaluating Oral Nicotine, Nicotine Lozenge, and 1 other intervention for Tobacco Dependence. Completed, enrolled 40 participants across 1 site.
Detailed Summary
A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after multiple-doses of nicotine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Dependence
CountriesSweden
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionMar 2009
Study CompletionApr 2009
First PostedMar 2010
TodayJul 2026
First PostedMar 10, 2010
Enrollment StartJan 1, 2009
Primary CompletionMar 1, 2009
Study CompletionApr 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 16.3 years ago
Interventions
Oral Nicotinedrug
Oral Nicotine either self-administered or provided by study personnel within 12 hours
Nicotine Lozengedrug
Nicotine lozenge marketed as NiQuitin™ 4 mg hourly within 12 hours
Nicotine gumdrug
Nicotine gum marketed as Nicorette® 4 mg hourly within 12 hours